Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2022-07-01
2023-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Therapy in Radiation Proctopathy
NCT01613534
Topical Versus Oral Metronidazole Following Excisional Haemorrhoidectomy
NCT03343509
Short Term Results of Platelet-rich Plasma in the Treatment of Chronic Anal Fissure
NCT04320498
The Use of Platelet-rich Plasma in the Treatment of Chronic Anal Fissure
NCT05837403
A Clinical Study on Alleviating Hemorrhoids-related Symptoms of Pelvic Radiation Therapy
NCT07175584
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ziverel
Within a first flexible rectoscopy (Day 1) the product will be applied transanally. Then the patients will apply it as enemas twice daily for 7 days. On day 8 (after treatment completion), and on day 31 (after 23 days of no treatment) follow-up flexible rectoscopies will be performed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* current or prior radiation therapy in the pelvic area;
* patients with complications connected to the radiation therapy.
Exclusion Criteria
* non-adherence to study protocol;
* pregnancy.
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barmherzige Brüder Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ILIYAN ILIEV
Principal Investigator, General Surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bernhard Dauser, Assoc. Prof.
Role: STUDY_CHAIR
Krankenhaus der Barmherzige Brüder Wien
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Krankenhaus der Barmherzigen Brüder
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202207-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.